Access the full text.
Sign up today, get DeepDyve free for 14 days.
Zhong Jiang, P. Chu, B. Woda, Qin Liu, K. Balaji, K. Rock, Chin-Lee Wu (2008)
Combination of Quantitative IMP3 and Tumor Stage: A New System to Predict Metastasis for Patients with Localized Renal Cell CarcinomasClinical Cancer Research, 14
(2010)
Usefulness of EZH2 and IMP3 in discriminating high grade neuroendocrine carcinoma from carcinoids in small biopsies
(2003)
diction of survival in early stage squamous cell carcinomas
M. Lechpammer, M. Resnick, E. Sabo, E. Yakirevich, Wesley Greaves, K. Sciandra, Rosemarie Tavares, Lelia Noble, R. DeLellis, L. Wang (2008)
The diagnostic and prognostic utility of claudin expression in renal cell neoplasmsModern Pathology, 21
N. Hoffmann, Y. Sheinin, C. Lohse, A. Parker, B. Leibovich, Zhong Jiang, E. Kwon (2008)
External validation of IMP3 expression as an independent prognostic marker for metastatic progression and death for patients with clear cell renal cell carcinomaCancer, 112
((2010))
Usefulness of EZH2 and IMP3 in discriminating high grade neuroendocrine carcinoma from carcinoids in small biopsies and fine needle aspiration specimens of the lung, 23
G. Bellezza, A. Cavaliere, A. Sidoni (2009)
IMP3 expression in non-small cell lung cancer.Human pathology, 40 8
Jennifer Findeis-Hosey, Qi Yang, B. Spaulding, Hanlin Wang, Hao-dong Xu (2010)
IMP3 expression is correlated with histologic grade of lung adenocarcinoma.Human pathology, 41 4
Y. Jeng, Cheng‐Chi Chang, F. Hu, Han‐Yi Chou, Hsin-Lien Kao, Ting-Huang Wang, H. Hsu (2008)
RNA‐binding protein insulin‐like growth factor II mRNA‐binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinomaHepatology, 48
Jacob Nielsen, J. Christiansen, J. Lykke-Andersen, A. Johnsen, U. Wewer, F. Nielsen (1999)
A Family of Insulin-Like Growth Factor II mRNA-Binding Proteins Represses Translation in Late DevelopmentMolecular and Cellular Biology, 19
(2009)
Insulin-like growth factor-2 mRNA binding protein 3 (IGF2BP3) expression may be a marker for an unfavorable prognosis in pancreatic ductal adenocarcinoma
Jonas Vikesaa, T. Hansen, L. Jønson, R. Borup, U. Wewer, J. Christiansen, F. Nielsen (2006)
RNA‐binding IMPs promote cell adhesion and invadopodia formationThe EMBO Journal, 25
(2008)
An oncofetal protein, IMP3: a novel biomarker to predict tumor progression in the low grade Ta urothelial carcinoma of the bladder
(2010)
IMP3: an immunohistochemical marker for invasive squamous cell carcinoma and its high-grade precursor lesions of the lung
Hao-dong Xu, P. Bourne, B. Spaulding, Hanlin Wang (2007)
High-grade neuroendocrine carcinomas of the lung express K homology domain containing protein overexpressed in cancer but carcinoid tumors do not.Human pathology, 38 4
Tongtong Wang, L. Fan, Yoshihiro Watanabe, P. Mcneill, G. Moulton, C. Bangur, G. Fanger, M. Okada, Y. Inoue, D. Persing, S. Reed, S. Reed (2003)
L523S, an RNA-binding protein as a potential therapeutic target for lung cancerBritish Journal of Cancer, 88
B. Liao, Yan Hu, D. Herrick, G. Brewer (2005)
The RNA-binding Protein IMP-3 Is a Translational Activator of Insulin-like Growth Factor II Leader-3 mRNA during Proliferation of Human K562 Leukemia Cells*Journal of Biological Chemistry, 280
Friederike Mueller-Pillasch, Barbara Pohl, M. Wilda, U. Lacher, M. Beil, C. Wallrapp, H. Hameister, W. Knöchel, G. Adler, T. Gress (1999)
Expression of the highly conserved RNA binding protein KOC in embryogenesisMechanisms of Development, 88
Friederike Müeller-Pillasch, U. Lacher, C. Wallrapp, A. Micha, F. Zimmerhackl, H. Hameister, G. Varga, H. Friess, M. Büchler, H. Beger, M. Vilá, G. Adler, T. Gress (1997)
Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing proteinOncogene, 14
Zhong Jiang, C. Lohse, P. Chu, Chin-Lee Wu, B. Woda, K. Rock, E. Kwon (2008)
Oncofetal protein IMP3Cancer, 112
((2008))
Oncofetal protein IMP3: a novel molecular marker that predicts metastasis of papillary and chromophobe renal cell carcinomas, 112
((2008))
Tissue microarray study of RNA-binding protein IMP3 in primary non-small cell lung cancers: prediction of survival in early stage squamous cell carcinomas, 21
R. Yantiss, B. Woda, G. Fanger, M. Kalos, G. Whalen, H. Tada, D. Andersen, K. Rock, K. Dresser (2005)
KOC (K Homology Domain Containing Protein Overexpressed in Cancer): A Novel Molecular Marker That Distinguishes Between Benign and Malignant Lesions of the PancreasThe American Journal of Surgical Pathology, 29
Zhong Jiang, P. Chu, B. Woda, K. Rock, Qin Liu, C. Hsieh, Cuizhen Li, Wengang Chen, H. Duan, Scott Mcdougal, Chin-Lee Wu (2006)
Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.The Lancet. Oncology, 7 7
Jennifer Findeis-Hosey, Hao-dong Xu (2011)
The use of insulin like-growth factor II messenger RNA binding protein-3 in diagnostic pathology.Human pathology, 42 3
L. Sitnikova, Gary Mendese, Qin Liu, B. Woda, D. Lu, K. Dresser, S. Mohanty, K. Rock, Zhong Jiang (2008)
IMP3 Predicts Aggressive Superficial Urothelial Carcinoma of the BladderClinical Cancer Research, 14
AbstractInsulin-like growth factor II-messenger RNA-binding protein 3 (IMP3) is an oncofetal RNA-binding protein that promotes tumor cell proliferation by enhancing IGF-II protein synthesis and inducing cell adhesion and invasion by stabilizing CD44 mRNA. IMP3 expression has been studied in many human neoplasms with growing evidence that IMP3 is a biomarker of enhanced tumor aggressiveness. IMP3 expression has been correlated with a poorer phenotypic profile including increased risk of metastases and decreased survival. Only a few studies have examined IMP3 expression in lung cancers. We review here the literature concerning IMP3 expression in lung neoplasms, specifically adenocarcinoma, squamous cell carcinoma, and neuroendocrine tumors of the lung. IMP3 immunohistochemical expression was reported in 27-55% of cases of primary pulmonary adenocarcinoma and in 75-90% of cases of squamous cell carcinoma of the lung. In adenocarcinoma, IMP3 expression was reported to be correlated with more poorly differentiated histological grade, advanced stage of disease and lymph node metastases. IMP3 expression also may be a marker of high grade pre-invasive squamous lesions including high grade dysplasia and carcinoma in situ. In neuroendocrine tumors of the lung, IMP3 expression was expressed in all reported cases of large cell neuroendocrine carcinoma and small cell lung carcinoma, but expression was limited in carcinoid tumors. Overall, IMP3 appears to be a useful diagnostic marker for lung cancer pathology including for discriminating high grade neuroendocrine tumors and low grade carcinoids and for identifying high grade pre-invasive squamous lesions.
Biotechnic & Histochemistry – Taylor & Francis
Published: Jan 1, 2012
Keywords: adenocarcinoma; dysplasia; IGF2BP3; IMP3; KOC; L523S; lung; malignancy; NETL; neuroendocrine tumor; oncoprotein; squamous cell carcinoma
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.